Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
暂无分享,去创建一个
C. Eckert | G. Henze | K. Seeger | W. Ludwig | L. Karawajew | R. Kirschner-Schwabe | J. Hof | S. Shalapour | P. Rhein | A. von Stackelberg | C. Hagemeier | G. Körner | S. Krentz | Claudia van Schewick